• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胰腺导管腺癌中的自身抗体特征

Autoantibody signature in human ductal pancreatic adenocarcinoma.

作者信息

Tomaino Barbara, Cappello Paola, Capello Michela, Fredolini Claudia, Ponzetto Antonio, Novarino Anna, Ciuffreda Libero, Bertetto Oscar, De Angelis Claudio, Gaia Enzo, Salacone Paola, Milella Michele, Nisticò Paola, Alessio Massimo, Chiarle Roberto, Giuffrida Maria G, Giovarelli Mirella, Novelli Francesco

机构信息

Center for Experimental Research and Medical Studies and University of Turin, San Giovanni Battista Hospital, Turin, Italy.

出版信息

J Proteome Res. 2007 Oct;6(10):4025-31. doi: 10.1021/pr070281a. Epub 2007 Sep 8.

DOI:10.1021/pr070281a
PMID:17824682
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by rapid progression, invasiveness, and resistance to treatment. It is the fourth leading cause of cancer death with a 2% 5-year survival rate. Biomarkers for its early detection are lacking. This study was designed to use a proteomics-based approach as a means of identifying antigens that elicit a humoral response in PDAC patients. Antibodies against PDAC-associated antigens are useful for early cancer diagnosis and therapy. Proteins from PDAC cell lines were separated by 2-DE, and the serum IgG reactivity of 70 PDAC patients, 40 healthy subjects (HS), 30 non-PDAC tumor patients, and 15 chronic pancreatitis (CP) patients was tested by Western blot analysis. Spots specifically recognized by PDAC sera and revealed by mass spectrometry corresponded to metabolic enzymes or cytoskeletal proteins. Most were up-regulated in PDAC tissues. Thus, it seems that metabolic enzymes and cytoskeletal proteins are specific targets of the humoral response during PDAC. The results of further studies of these serological-defined antigens could be of diagnostic and therapeutic significance in PDAC.

摘要

胰腺导管腺癌(PDAC)是一种极具侵袭性的恶性肿瘤,其特点是进展迅速、具有侵袭性且对治疗有抗性。它是癌症死亡的第四大主要原因,5年生存率仅为2%。目前缺乏用于早期检测的生物标志物。本研究旨在采用基于蛋白质组学的方法来识别在PDAC患者中引发体液免疫反应的抗原。针对PDAC相关抗原的抗体对癌症早期诊断和治疗有用。通过二维电泳分离PDAC细胞系的蛋白质,并用蛋白质印迹分析检测70例PDAC患者、40例健康受试者(HS)、30例非PDAC肿瘤患者和15例慢性胰腺炎(CP)患者血清IgG的反应性。经质谱鉴定,PDAC血清特异性识别并显示的斑点对应于代谢酶或细胞骨架蛋白。大多数在PDAC组织中上调。因此,代谢酶和细胞骨架蛋白似乎是PDAC期间体液免疫反应的特异性靶点。对这些血清学定义抗原的进一步研究结果可能对PDAC具有诊断和治疗意义。

相似文献

1
Autoantibody signature in human ductal pancreatic adenocarcinoma.人胰腺导管腺癌中的自身抗体特征
J Proteome Res. 2007 Oct;6(10):4025-31. doi: 10.1021/pr070281a. Epub 2007 Sep 8.
2
Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.磷酸甘油酸激酶1在胰腺导管腺癌中的过表达及血清水平升高
Proteomics. 2006 Apr;6(7):2259-72. doi: 10.1002/pmic.200500345.
3
An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.胰腺癌中针对钙网蛋白异构体的自身抗体介导的免疫反应。
Cancer Res. 2004 Aug 1;64(15):5504-10. doi: 10.1158/0008-5472.CAN-04-0077.
4
Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.用于检测胰腺导管腺癌生物标志物的比较蛋白质组学分析。
J Clin Pathol. 2008 Jan;61(1):49-58. doi: 10.1136/jcp.2006.044735. Epub 2007 Apr 5.
5
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.一种新型的胰腺导管腺癌相关抗原α-烯醇化酶可在胰腺癌中引发体液和细胞的综合反应。
Int J Cancer. 2009 Aug 1;125(3):639-48. doi: 10.1002/ijc.24355.
6
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer.循环中磷酸化烯醇酶自身抗体是胰腺癌的一个标志。
J Proteome Res. 2011 Jan 7;10(1):105-12. doi: 10.1021/pr100213b. Epub 2010 Jun 10.
7
Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.蛋白质组学分析以鉴定胰腺导管腺癌中的生物标志物蛋白。
ANZ J Surg. 2008 Apr;78(4):245-51. doi: 10.1111/j.1445-2197.2008.04429.x.
8
Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.肌动蛋白-4 在原发性和转移性胰腺导管腺癌中的表达。
Pancreas. 2009 Nov;38(8):968-76. doi: 10.1097/MPA.0b013e3181b28d6f.
9
[Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].[慢性胰腺炎和胰腺导管腺癌中黏蛋白的免疫组织化学研究]
Arkh Patol. 2008 Jul-Aug;70(4):13-7.
10
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.CXC趋化因子CXCL16在胰腺导管腺癌中的表达及潜在功能
Int J Oncol. 2008 Aug;33(2):297-308.

引用本文的文献

1
Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma.对磷酸化氨基酸产生高滴度类别转换抗体反应在胰腺导管腺癌中很普遍。
Front Immunol. 2025 Mar 28;16:1501943. doi: 10.3389/fimmu.2025.1501943. eCollection 2025.
2
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.在胰腺癌患者中,化疗重塑了 T 淋巴细胞的基因表达谱和抗原受体库,并增强了它们对肿瘤相关抗原的效应器反应。
Front Immunol. 2024 Aug 8;15:1427424. doi: 10.3389/fimmu.2024.1427424. eCollection 2024.
3
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.
PI3Kγ 抑制联合 DNA 疫苗接种释放出依赖 B 细胞的抗肿瘤免疫,从而抑制胰腺癌。
J Exp Clin Cancer Res. 2024 Jun 1;43(1):157. doi: 10.1186/s13046-024-03080-1.
4
Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy.胰腺导管内乳头状黏液性肿瘤(IPMN)患者血液中自身反应性抗体用于分级区分和恶性肿瘤检测
Cancers (Basel). 2022 Jul 22;14(15):3562. doi: 10.3390/cancers14153562.
5
The dark side of immunotherapy: pancreatic cancer.免疫疗法的阴暗面:胰腺癌
Cancer Drug Resist. 2020 May 11;3(3):491-520. doi: 10.20517/cdr.2020.13. eCollection 2020.
6
B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma.B淋巴细胞在胰腺腺癌病理生理学中的作用
Front Immunol. 2022 Mar 14;13:867902. doi: 10.3389/fimmu.2022.867902. eCollection 2022.
7
Liquid biopsy approach to pancreatic cancer.胰腺癌的液体活检方法。
World J Gastrointest Oncol. 2021 Oct 15;13(10):1263-1287. doi: 10.4251/wjgo.v13.i10.1263.
8
Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment.烯醇化酶 1,一种兼性 Moonlighting 蛋白,作为癌症治疗的潜在靶点。
Int J Biol Sci. 2021 Sep 21;17(14):3981-3992. doi: 10.7150/ijbs.63556. eCollection 2021.
9
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer.糖酵解途径作为胰腺癌新型肿瘤免疫治疗的靶点。
Molecules. 2021 Mar 15;26(6):1642. doi: 10.3390/molecules26061642.
10
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.在胰腺癌中,化疗可增强抗肿瘤反应对肿瘤相关抗原并增强 DNA 疫苗接种的效果。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001071.